Investigation of Dermatological Manifestations in Maintenance Hemodialysis Patients

    Elif Demirci Saadet, Mehmet Emin Demir
    Image of study
    TLDR Patients on long-term hemodialysis often have skin problems related to their treatment.
    The study investigated dermatological manifestations in patients with end-stage renal disease undergoing maintenance hemodialysis. It aimed to describe the characteristics of these skin findings and their relationship with demographic and clinical features. Patients from a private hemodialysis clinic were prospectively analyzed, examining factors such as age, gender, type of vascular access, hemodialysis duration, and various blood parameters. The study documented the dermatological findings and calculated calcium x phosphorus levels, with statistical significance set at p<0.05.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 31 results

      community Better then Minoxidil( at least for me and my family)

      in Treatment  42 upvotes 7 months ago
      Capronium Chloride and Trichoxidil are suggested as better alternatives to Minoxidil for hair growth without heart side effects. The Japanese Dermatological Association recommends topical Minoxidil over Capronium Chloride.

      community Stop wasting time – start fin + min ASAP!

      in Chat 2 years ago
      A user's experience with treating hair loss using finasteride and minoxidil, as well as advice from other users that they should try finasteride alone first before committing to minoxidil.

      community Growth Stimulants that aren't Minoxidil...?

      in Research/Science  7 upvotes 5 months ago
      The user is exploring hair growth stimulants other than Minoxidil, mentioning Stemoxydine, various peptides, drugs like Latanoprost and Bimatoprost, and natural remedies such as Rosemary Oil and Caffeine. They express concerns about the long-term effectiveness and safety of these alternatives and seek more information on viable options for hair regrowth.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 5 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

    Similar Research

    5 / 1000+ results